an overall trendp = 0.17
Preneoplastic cells showed also an overall trend of increased ERK signaling when treated with OSM (133 ± 66%; p = 0.17) or IL-6 (53 ± 38%; p = 0.01) but not with EGF (85 ± 67%; p = 0.46).
Preneoplastic cells showed also an overall trend of increased ERK signaling when treated with OSM (133 ± 66%; p = 0.17) or IL-6 (53 ± 38%; p = 0.01) but not with EGF (85 ± 67%; p = 0.46).